Literature DB >> 8535322

Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.

D F Roychowdhury1, C A Linker.   

Abstract

A patient underwent an HLA-identical ABO-compatible allogeneic bone marrow transplant for aplastic anemia. She then developed pure red cell aplasia which was treated successfully with antithymocyte globulin and methylprednisolone, after failing to respond to intravenous immune globulin infusion.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8535322

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  5 in total

1.  Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series.

Authors:  Alexandra Gomez-Arteaga; Michael Scordo; Roni Tamari; Josel D Ruiz; Ann A Jakubowski; Esperanza B Papadopoulos; Sergio A Giralt; Miguel-Angel Perales; Hugo R Castro-Malaspina; Craig S Sauter; Parastoo B Dahi
Journal:  Bone Marrow Transplant       Date:  2020-05-18       Impact factor: 5.483

Review 2.  Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.

Authors:  Javier Marco-Ayala; Inés Gómez-Seguí; Guillermo Sanz; Pilar Solves
Journal:  Bone Marrow Transplant       Date:  2020-11-14       Impact factor: 5.483

3.  Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins.

Authors:  Georg Stussi; Jörg Halter; Eveline Bucheli; Piero V Valli; Lutz Seebach; Jürg Gmür; Alois Gratwohl; Urs Schanz; Jakob R Passweg; Jörg D Seebach
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

4.  Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sung-Hoon Jung; Jae-Sook Ahn; Deok-Hwan Yang; Hyung Chul Park; Soo-Young Bae; Yeo-Kyeoung Kim; Hyeoung-Joon Kim; Je-Jung Lee
Journal:  Case Rep Oncol       Date:  2012-02-29

Review 5.  Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

Authors:  Richard K Burt; Shimon Slavin; William H Burns; Alberto M Marmont
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.